{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T11:09:41Z","timestamp":1760267381971},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2015,11,16]],"date-time":"2015-11-16T00:00:00Z","timestamp":1447632000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Comput Aided Mol Des"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1007\/s10822-015-9880-1","type":"journal-article","created":{"date-parts":[[2015,11,16]],"date-time":"2015-11-16T09:42:48Z","timestamp":1447666968000},"page":"1109-1122","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Predicting the relative binding affinity of mineralocorticoid receptor antagonists by density functional methods"],"prefix":"10.1007","volume":"29","author":[{"given":"Katarina","family":"Roos","sequence":"first","affiliation":[]},{"given":"Anders","family":"Hogner","sequence":"additional","affiliation":[]},{"given":"Derek","family":"Ogg","sequence":"additional","affiliation":[]},{"given":"Martin J.","family":"Packer","sequence":"additional","affiliation":[]},{"given":"Eva","family":"Hansson","sequence":"additional","affiliation":[]},{"given":"Kenneth L.","family":"Granberg","sequence":"additional","affiliation":[]},{"given":"Emma","family":"Evertsson","sequence":"additional","affiliation":[]},{"given":"Anneli","family":"Nordqvist","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2015,11,16]]},"reference":[{"key":"9880_CR1","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1146\/annurev.nu.16.070196.002303","volume":"16","author":"CE Fardella","year":"1996","unstructured":"Fardella CE, Miller WL (1996) Molecular biology of mineralocorticoid metabolism. Annu Rev Nutr 16:443\u2013470","journal-title":"Annu Rev Nutr"},{"key":"9880_CR2","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/clc.20324","volume":"31","author":"A Struthers","year":"2008","unstructured":"Struthers A, Krum H, Williams GH (2008) A comparison of the aldosterone-blocking agents eplerenone and spironolactone. Clin Cardiol 31:153\u2013158","journal-title":"Clin Cardiol"},{"key":"9880_CR3","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/S0140-6736(62)92199-2","volume":"1","author":"WI Cranston","year":"1962","unstructured":"Cranston WI, Juel-Jensen BE (1962) The effects of spironolactone and chlorthalidone on arterial pressure. Lancet 1:1161\u20131164","journal-title":"Lancet"},{"key":"9880_CR4","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.mce.2003.10.005","volume":"217","author":"SM Garthwaite","year":"2004","unstructured":"Garthwaite SM, McMahon EG (2004) The evolution of aldosterone antagonists. Mol Cell Endocrinol 217:27\u201331","journal-title":"Mol Cell Endocrinol"},{"key":"9880_CR5","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.2337\/diacare.28.9.2106","volume":"28","author":"K Rossing","year":"2005","unstructured":"Rossing K, Schjoedt KJ, Smidt UM, Boomsma F, Parving HH (2005) Beneficial effects of adding spironolactone to recommended antihypertensive treatment in diabetic nephropathy: a randomized, double-masked, cross-over study. Diabetes Care 28:2106\u20132112","journal-title":"Diabetes Care"},{"key":"9880_CR6","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1161\/01.HYP.0000044937.95080.E9","volume":"41","author":"A Sato","year":"2003","unstructured":"Sato A, Hayashi K, Naruse M, Saruta T (2003) Effectiveness of aldosterone blockade in patients with diabetic nephropathy. Hypertension 41:64\u201368","journal-title":"Hypertension"},{"key":"9880_CR7","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/sj.ki.5001580","volume":"70","author":"KJ Schjoedt","year":"2006","unstructured":"Schjoedt KJ, Rossing K, Juhl TR, Boomsma F, Tarnow L, Rossing P, Parving HH (2006) Beneficial impact of spironolactone on nephrotic range albuminuria in diabetic nephropathy. Kidney Int 70:536\u2013542","journal-title":"Kidney Int"},{"key":"9880_CR8","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1097\/01.hjh.0000249708.44016.5c","volume":"24","author":"AH Meiracker van den","year":"2006","unstructured":"van den Meiracker AH, Baggen RG, Pauli S, Lindemans A, Vulto AG, Poldermans D, Boomsma F (2006) Spironolactone in type 2 diabetic nephropathy: effects on proteinuria, blood pressure and renal function. J Hypertens 24:2285\u20132292","journal-title":"J Hypertens"},{"key":"9880_CR9","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1038\/ki.2011.48","volume":"79","author":"J Bertocchio","year":"2011","unstructured":"Bertocchio J, Warnock DG, Jaisser F (2011) Mineralocorticoid receptor activation and blockade: an emerging paradigm in chronic kidney disease. Kidney Int 79:1051\u20131060","journal-title":"Kidney Int"},{"key":"9880_CR10","doi-asserted-by":"crossref","first-page":"5983","DOI":"10.1016\/j.bmc.2013.07.043","volume":"21","author":"T Hasui","year":"2013","unstructured":"Hasui T, Ohra T, Ohyabu N, Asano K, Matsui H, Mizukami A, Habuka N, Sogabe S, Endo S, Siedem CS, Tang TP, Gauthier C, De Meese LA, Boyd SA, Fukumoto S (2013) Design, synthesis, and structure-activity relationships of dihydrofuran-2-one and dihydropyrrol-2-one derivatives as novel benzoxazin-3-one-based mineralocorticoid receptor antagonists. Bioorg Med Chem 21:5983\u20135994","journal-title":"Bioorg Med Chem"},{"key":"9880_CR11","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1038\/nsmb939","volume":"12","author":"J Fagart","year":"2005","unstructured":"Fagart J, Huyet J, Pinon GM, Rochel M, Mayer C, Rafestin-Oblin M (2005) Crystal structure of a mutant mineralocorticoid receptor responsible for hypertension. Nat Struct Mol Biol 12:554\u2013555","journal-title":"Nat Struct Mol Biol"},{"key":"9880_CR12","doi-asserted-by":"crossref","first-page":"31283","DOI":"10.1074\/jbc.M504098200","volume":"280","author":"RK Bledsoe","year":"2005","unstructured":"Bledsoe RK, Madauss KP, Holt JA, Apolito CJ, Lambert MH, Pearce KH, Stanley TB, Stewart EL, Trump RP, Willson TM, Williams SP (2005) A ligand-mediated hydrogen bond network required for the activation of the mineralocorticoid receptor. J Biol Chem 280:31283\u201331293","journal-title":"J Biol Chem"},{"key":"9880_CR13","doi-asserted-by":"crossref","first-page":"5428","DOI":"10.1016\/j.bmc.2014.07.038","volume":"22","author":"T Hasui","year":"2014","unstructured":"Hasui T, Ohyabu N, Ohra T, Fuji K, Sugimoto T, Fujimoto J, Asano K, Oosawa M, Shiotani S, Nishigaki N, Kusumoto K, Matsui H, Mizukami A, Habuka N, Sogabe S, Endo S, Ono M, Siedem CS, Tang TP, Gauthier C, De Meese LA, Boyd SA, Fukumoto S (2014) Discovery of 6-5-(4-fluorophenyl)-3-methyl-pyrazol-4-yl]-benzoxazin-3-one derivatives as novel selective nonsteroidal mineralocorticoid receptor antagonists. Bioorg Med Chem 22:5428\u20135445","journal-title":"Bioorg Med Chem"},{"key":"9880_CR14","unstructured":"Casimiro-Garcia A, Futatsugi K, Piotrowski DW (2011) Preparation of morpholine compounds as therapeutic mineralocorticoid receptor antagonists. WO2011141848A1"},{"key":"9880_CR15","unstructured":"Fukumoto S, Ohyabu N, Ohra T, Sugimoto T, Hasui T, Fuji K, Siedem CS, Gauthier C (2010) Preparation of pyrazole compounds as mineralocorticoid receptor antagonists. US20100094000A1"},{"key":"9880_CR16","unstructured":"Fukumoto S, Matsunaga N, Ohra T, Ohyabu N, Hasui T, Motoyaji T, Siedem CS, Tang TP, Demeese LA, Gauthier C (2007) Preparation of fused heterocycles as mineralocorticoid receptor antagonists. WO2007077961A2"},{"key":"9880_CR17","unstructured":"Michellys P, Petrassi HM, Richmond W, Pei W (2006) Compounds and compositions as modulators of steroid hormone nuclear receptors. WO2006015259"},{"key":"9880_CR18","unstructured":"Boyer SJ, Guo X, Wu D, Wu F (2012) Preparation of pyridyl ureas as mineralocorticoid receptor antagonists. WO2012064631A1"},{"key":"9880_CR19","doi-asserted-by":"crossref","first-page":"8616","DOI":"10.1021\/jm2011645","volume":"54","author":"T Hasui","year":"2011","unstructured":"Hasui T, Matsunaga N, Ora T, Ohyabu N, Nishigaki N, Imura Y, Igata Y, Matsui H, Motoyaji T, Tanaka T, Habuka N, Sogabe S, Ono M, Siedem CS, Tang TP, Gauthier C, De Meese LA, Boyd SA, Fukumoto S (2011) Identification of benzoxazin-3-one derivatives as novel, potent, and selective nonsteroidal mineralocorticoid receptor antagonists. J Med Chem 54:8616\u20138631","journal-title":"J Med Chem"},{"key":"9880_CR20","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/sj.embor.7400119","volume":"5","author":"Y Brelivet","year":"2004","unstructured":"Brelivet Y, Kammerer S, Rochel N, Poch O, Moras D (2004) Signature of the oligomeric behaviour of nuclear receptors at the sequence and structural level. EMBO Rep 5:423\u2013429","journal-title":"EMBO Rep"},{"key":"9880_CR21","doi-asserted-by":"crossref","first-page":"7957","DOI":"10.1021\/jm300806c","volume":"55","author":"DW Piotrowski","year":"2012","unstructured":"Piotrowski DW (2012) Mineralocorticoid receptor antagonists for the treatment of hypertension and diabetic nephropathy. J Med Chem 55:7957\u20137966","journal-title":"J Med Chem"},{"key":"9880_CR22","doi-asserted-by":"crossref","first-page":"5935","DOI":"10.1021\/jm401951t","volume":"57","author":"J Georgsson","year":"2014","unstructured":"Georgsson J, Bergstr\u00f6m F, Nordqvist A, Watson MJ, Blundell CD, Johansson MJ, Petersson AU, Yuan Z, Zhou Y, Kristensson L, Kakol-Palm D, Tyrchan C, Wellner E, Bauer U, Brodin P, Svensson Henriksson A (2014) GPR103 antagonists demonstrating anorexigenic activity in vivo: design and development of pyrrolo[2,3-c]pyridines that mimic the C-terminal Arg-Phe Motif of QRFP26. J Med Chem 57:5935\u20135948","journal-title":"J Med Chem"},{"key":"9880_CR23","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1021\/ml400519h","volume":"5","author":"A Nordqvist","year":"2014","unstructured":"Nordqvist A, Kristensson L, Johansson KE, Isaksson da Silva K, Fex T, Tyrchan C, Svensson Henriksson A, Nilsson K (2014) New hits as antagonists of GPR103 identified by HTS. ACS Med Chem Lett 5:527\u2013532","journal-title":"ACS Med Chem Lett"},{"key":"9880_CR24","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/nrd4163","volume":"13","author":"AL Hopkins","year":"2014","unstructured":"Hopkins AL, Keseru GM, Leeson PD, Rees DC, Reynolds CH (2014) The role of ligand efficiency metrics in drug discovery. Nat Rev Drug Discov 13:105\u2013121","journal-title":"Nat Rev Drug Discov"},{"key":"9880_CR25","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1017\/CBO9780511730412.009","volume-title":"Drug design: structure- and ligand-based approaches","author":"MS Head","year":"2010","unstructured":"Head MS (2010) Docking: a domesday report. In: Merz KM Jr, Ringe D, Reynolds CH (eds) Drug design: structure- and ligand-based approaches. Cambridge University Press, New York, p 98"},{"key":"9880_CR26","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1038\/nrd1549","volume":"3","author":"DB Kitchen","year":"2004","unstructured":"Kitchen DB, Decornez H, Furr JR, Bajorath J (2004) Docking and scoring in virtual screening for drug discovery: methods and applications. Nat Rev Drug Discov 3:935\u2013949","journal-title":"Nat Rev Drug Discov"},{"key":"9880_CR27","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.comptc.2013.11.020","volume":"1028","author":"C Barberot","year":"2014","unstructured":"Barberot C, Boisson JC, Gerard S, Khartabil H, Thiriot E, Monard G, Henon E (2014) AlgoGen: a tool coupling a linear-scaling quantum method with a genetic algorithm for exploring non-covalent interactions. Comput Theor Chem 1028:7\u201318","journal-title":"Comput Theor Chem"},{"key":"9880_CR28","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1002\/prot.20578","volume":"61","author":"X He","year":"2005","unstructured":"He X, Mei Y, Xiang Y, Zhang DW, Zhang JZH (2005) Quantum computational analysis for drug resistance of HIV-1 reverse transcriptase to nevirapine through point mutations. Proteins: Struct, Funct, Bioinf 61:423\u2013432","journal-title":"Proteins: Struct, Funct, Bioinf"},{"key":"9880_CR29","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1517\/17460440903440127","volume":"5","author":"Y Jing","year":"2010","unstructured":"Jing Y, Han K (2010) Quantum mechanical effect in protein\u2013ligand interaction. Expert Opin Drug Discov 5:33\u201349","journal-title":"Expert Opin Drug Discov"},{"key":"9880_CR30","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1002\/cplu.201300199","volume":"78","author":"M Lepsik","year":"2013","unstructured":"Lepsik M, Rezac J, Kolar M, Pecina A, Hobza P, Fanfrlik J (2013) The semiempirical quantum mechanical scoring function for in silico drug design. ChemPlusChem 78:921\u2013931","journal-title":"ChemPlusChem"},{"key":"9880_CR31","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1002\/jcc.23303","volume":"34","author":"L Rao","year":"2013","unstructured":"Rao L, Zhang IY, Guo W, Feng L, Meggers E, Xu X (2013) Nonfitting protein\u2013ligand interaction scoring function based on first-principles theoretical chemistry methods: development and application on kinase inhibitors. J Comput Chem 34:1636\u20131646","journal-title":"J Comput Chem"},{"key":"9880_CR32","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1021\/ct9006986","volume":"6","author":"P Soederhjelm","year":"2010","unstructured":"Soederhjelm P, Kongsted J, Ryde U (2010) Ligand affinities estimated by quantum chemical calculations. J Chem Theory Comput 6:1726\u20131737","journal-title":"J Chem Theory Comput"},{"key":"9880_CR33","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.csbj.2015.02.004","volume":"13","author":"ND Yilmazer","year":"2015","unstructured":"Yilmazer ND, Korth M (2015) Enhanced semiempirical QM methods for biomolecular interactions. Comput Struct Biotechnol J 13:169\u2013175","journal-title":"Comput Struct Biotechnol J"},{"key":"9880_CR34","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1517\/17460441.2013.752812","volume":"8","author":"D Mucs","year":"2013","unstructured":"Mucs D, Bryce RA (2013) The application of quantum mechanics in structure-based drug design. Expert Opin Drug Discov 8:263\u2013276","journal-title":"Expert Opin Drug Discov"},{"key":"9880_CR35","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.drudis.2007.07.006","volume":"12","author":"K Raha","year":"2007","unstructured":"Raha K, Peters MB, Wang B, Yu N, Wollacott AM, Westerhoff LM, Merz KM Jr (2007) The role of quantum mechanics in structure-based drug design. Drug Discov Today 12:725\u2013731","journal-title":"Drug Discov Today"},{"key":"9880_CR36","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1021\/ci400374z","volume":"54","author":"K Roos","year":"2014","unstructured":"Roos K, Viklund J, Meuller J, Kaspersson K, Svensson M (2014) Potency prediction of \u03b2-secretase (BACE-1) inhibitors using density functional methods. J Chem Inf Model 54:818\u2013825","journal-title":"J Chem Inf Model"},{"key":"9880_CR37","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1073\/pnas.1114017109","volume":"109","author":"L Wang","year":"2012","unstructured":"Wang L, Berne BJ, Friesner RA (2012) On achieving high accuracy and reliability in the calculation of relative protein\u2013ligand binding affinities. Proc Natl Acad Sci USA 109:1937\u20131942","journal-title":"Proc Natl Acad Sci USA"},{"key":"9880_CR38","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s10822-013-9644-8","volume":"27","author":"G Madhavi Sastry","year":"2013","unstructured":"Madhavi Sastry G, Adzhigirey M, Day T, Annabhimoju R, Sherman W (2013) Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments. J Comput-Aided Mol Des 27:221\u2013234","journal-title":"J Comput-Aided Mol Des"},{"key":"9880_CR39","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1021\/ct100578z","volume":"7","author":"MHM Olsson","year":"2011","unstructured":"Olsson MHM, Sondergaard CR, Rostkowski M, Jensen JH (2011) PROPKA3: consistent treatment of internal and surface residues in empirical pKa predictions. J Chem Theory Comput 7:525\u2013537","journal-title":"J Chem Theory Comput"},{"key":"9880_CR40","unstructured":"Protein Preparation Wizard 2014-2; Epik version 2.4, Impact version 5.9, Prime 3.2 (2014) Schr\u00f6dinger, LLC, New York"},{"key":"9880_CR41","doi-asserted-by":"crossref","unstructured":"Schr\u00f6dinger Release 2013-1: MacroModel 10.0 (2013) Schr\u00f6dinger, LLC, New York","DOI":"10.1155\/2013\/170835"},{"key":"9880_CR42","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1021\/jm0306430","volume":"47","author":"RA Friesner","year":"2004","unstructured":"Friesner RA, Banks JL, Murphy RB, Halgren TA, Klicic JJ, Mainz DT, Repasky MP, Knoll EH, Shelley M, Perry JK, Shaw DE, Francis P, Shenkin PS (2004) Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. J Med Chem 47:1739\u20131749","journal-title":"J Med Chem"},{"key":"9880_CR43","unstructured":"Glide 6.3 (2014) Schr\u00f6dinger, LLC, New York"},{"key":"9880_CR44","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1021\/jm030644s","volume":"47","author":"TA Halgren","year":"2004","unstructured":"Halgren TA, Murphy RB, Friesner RA, Beard HS, Frye LL, Pollard WT, Banks JL (2004) Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening. J Med Chem 47:1750\u20131759","journal-title":"J Med Chem"},{"key":"9880_CR45","doi-asserted-by":"crossref","first-page":"6177","DOI":"10.1021\/jm051256o","volume":"49","author":"RA Friesner","year":"2006","unstructured":"Friesner RA, Murphy RB, Repasky MP, Frye LL, Greenwood JR, Halgren TA, Sanschagrin PC, Mainz DT (2006) Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein\u2013ligand complexes. J Med Chem 49:6177\u20136196","journal-title":"J Med Chem"},{"key":"9880_CR46","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1002\/qua.24481","volume":"113","author":"AD Bochevarov","year":"2013","unstructured":"Bochevarov AD, Harder E, Hughes TF, Greenwood JR, Braden DA, Philipp DM, Rinaldo D, Halls MD, Zhang J, Friesner RA (2013) Jaguar: a high-performance quantum chemistry software program with strengths in life and materials sciences. Int J Quantum Chem 113:2110\u20132142","journal-title":"Int J Quantum Chem"},{"key":"9880_CR47","unstructured":"Jaguar 8.2 (2013) Schr\u00f6dinger, LLC, New York"},{"key":"9880_CR48","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s00214-007-0310-x","volume":"120","author":"Y Zhao","year":"2008","unstructured":"Zhao Y, Truhlar DG (2008) The M06 suite of density functionals for main group thermochemistry, thermochemical kinetics, noncovalent interactions, excited states, and transition elements: two new functionals and systematic testing of four M06-class functionals and 12 other functionals. Theor Chem Acc 120:215\u2013241","journal-title":"Theor Chem Acc"},{"key":"9880_CR49","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1021\/ct7001418","volume":"3","author":"AV Marenich","year":"2007","unstructured":"Marenich AV, Olson RM, Kelly CP, Cramer CJ, Truhlar DG (2007) Self-consistent reaction field model for aqueous and nonaqueous solutions based on accurate polarized partial charges. J Chem Theory Comput 3:2011\u20132033","journal-title":"J Chem Theory Comput"},{"key":"9880_CR50","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1021\/ct7001607","volume":"3","author":"RM Olson","year":"2007","unstructured":"Olson RM, Marenich AV, Cramer CJ, Truhlar DG (2007) Charge model 4 and intramolecular charge polarization. J Chem Theory Comput 3:2046\u20132054","journal-title":"J Chem Theory Comput"},{"key":"9880_CR51","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s00775-009-0511-y","volume":"14","author":"PEM Siegbahn","year":"2009","unstructured":"Siegbahn PEM, Himo F (2009) Recent developments of the quantum chemical cluster approach for modeling enzyme reactions. J Biol Inorg Chem 14:643\u2013651","journal-title":"J Biol Inorg Chem"},{"key":"9880_CR52","doi-asserted-by":"crossref","first-page":"5648","DOI":"10.1063\/1.464913","volume":"98","author":"AD Becke","year":"1993","unstructured":"Becke AD (1993) Density-functional thermochemistry. III. The role of exact exchange. J Chem Phys 98:5648\u20135652","journal-title":"J Chem Phys"},{"key":"9880_CR53","doi-asserted-by":"crossref","first-page":"154104","DOI":"10.1063\/1.3382344","volume":"132","author":"S Grimme","year":"2010","unstructured":"Grimme S, Antony J, Ehrlich S, Krieg H (2010) A consistent and accurate ab initio parametrization of density functional dispersion correction (DFT-D) for the 94 elements H-Pu. J Chem Phys 132:154104","journal-title":"J Chem Phys"},{"key":"9880_CR54","unstructured":"Desmond Molecular Dynamics System 4.1 (2015) D. E. Shaw Research, New York"},{"key":"9880_CR55","unstructured":"Maestro-Desmond Interoperability Tools 4.1 (2015) Schr\u00f6dinger, LLC, New York"},{"key":"9880_CR56","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1021\/ct300911a","volume":"9","author":"L Wang","year":"2013","unstructured":"Wang L, Deng Y, Knight JL, Wu Y, Kim B, Sherman W, Shelley JC, Lin T, Abel R (2013) Modeling local structural rearrangements using FEP\/REST: application to relative binding affinity predictions of CDK2 inhibitors. J Chem Theory Comput 9:1282\u20131293","journal-title":"J Chem Theory Comput"},{"key":"9880_CR57","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.1021\/ja512751q","volume":"137","author":"L Wang","year":"2015","unstructured":"Wang L, Wu Y, Deng Y, Kim B, Pierce L, Krilov G, Lupyan D, Robinson S, Dahlgren MK, Greenwood J, Romero DL, Masse C, Knight JL, Steinbrecher T, Beuming T, Damm W, Harder E, Sherman W, Brewer M, Wester R, Murcko M, Frye L, Farid R, Lin T, Mobley DL, Jorgensen WL, Berne BJ, Friesner RA, Abel R (2015) Accurate and reliable prediction of relative ligand binding potency in prospective drug discovery by way of a modern free-energy calculation protocol and force field. J Am Chem Soc 137:2695\u20132703","journal-title":"J Am Chem Soc"},{"key":"9880_CR58","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1038\/nrd2445","volume":"6","author":"PD Leeson","year":"2007","unstructured":"Leeson PD, Springthorpe B (2007) The influence of drug-like concepts on decision-making in medicinal chemistry. Nat Rev Drug Discov 6:881\u2013890","journal-title":"Nat Rev Drug Discov"},{"key":"9880_CR59","doi-asserted-by":"crossref","first-page":"9997","DOI":"10.1073\/pnas.96.18.9997","volume":"96","author":"ID Kuntz","year":"1999","unstructured":"Kuntz ID, Chen K, Sharp KA, Kollman PA (1999) The maximal affinity of ligands. Proc Natl Acad Sci USA 96:9997\u201310002","journal-title":"Proc Natl Acad Sci USA"},{"key":"9880_CR60","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/nrd3367","volume":"10","author":"MP Gleeson","year":"2011","unstructured":"Gleeson MP, Hersey A, Montanari D, Overington J (2011) Probing the links between in vitro potency, ADMET and physicochemical parameters. Nat Rev Drug Discov 10:197\u2013208","journal-title":"Nat Rev Drug Discov"},{"key":"9880_CR61","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1021\/ci500081m","volume":"54","author":"Y Li","year":"2014","unstructured":"Li Y, Han L, Liu Z, Wang R (2014) Comparative assessment of scoring functions on an updated benchmark: 2. Evaluation methods and general results. J Chem Inf Model 54:1717\u20131736","journal-title":"J Chem Inf Model"},{"key":"9880_CR62","doi-asserted-by":"crossref","first-page":"5912","DOI":"10.1021\/jm050362n","volume":"49","author":"GL Warren","year":"2006","unstructured":"Warren GL, Andrews CW, Capelli A, Clarke B, LaLonde J, Lambert MH, Lindvall M, Nevins N, Semus SF, Senger S, Tedesco G, Wall ID, Woolven JM, Peishoff CE, Head MS (2006) A critical assessment of docking programs and scoring functions. J Med Chem 49:5912\u20135931","journal-title":"J Med Chem"},{"key":"9880_CR63","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1747-0285.2005.00314.x","volume":"67","author":"AJ Ruben","year":"2006","unstructured":"Ruben AJ, Kiso Y, Freire E (2006) Overcoming roadblocks in lead optimization: a thermodynamic perspective. Chem Biol Drug Des 67:2\u20134","journal-title":"Chem Biol Drug Des"},{"key":"9880_CR64","doi-asserted-by":"crossref","first-page":"7706","DOI":"10.1021\/jm900713y","volume":"52","author":"I Shamovsky","year":"2009","unstructured":"Shamovsky I, de Graaf C, Alderin L, Bengtsson M, Bladh H, Borjesson L, Connolly S, Dyke HJ, van den Heuvel M, Johansson H, Josefsson B, Kristoffersson A, Linnanen T, Lisius A, Mannikko R, Norden B, Price S, Ripa L, Rognan D, Rosendahl A, Skrinjar M, Urbahns K (2009) Increasing selectivity of CC chemokine receptor 8 antagonists by engineering nondesolvation related interactions with the intended and off-target binding sites. J Med Chem 52:7706\u20137723","journal-title":"J Med Chem"},{"key":"9880_CR65","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1021\/ct100641a","volume":"7","author":"J Contreras-Garcia","year":"2011","unstructured":"Contreras-Garcia J, Johnson ER, Keinan S, Chaudret R, Piquemal J, Beratan DN, Yang W (2011) NCIPLOT: a program for plotting noncovalent interaction regions. J Chem Theory Comput 7:625\u2013632","journal-title":"J Chem Theory Comput"},{"key":"9880_CR66","doi-asserted-by":"crossref","first-page":"6498","DOI":"10.1021\/ja100936w","volume":"132","author":"ER Johnson","year":"2010","unstructured":"Johnson ER, Keinan S, Mori-Sanchez P, Contreras-Garcia J, Cohen AJ, Yang W (2010) Revealing noncovalent interactions. J Am Chem Soc 132:6498\u20136506","journal-title":"J Am Chem Soc"},{"key":"9880_CR67","unstructured":"OPLS 2.1 (2014) Schr\u00f6dinger, LLC, New York"},{"key":"9880_CR68","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1016\/j.drudis.2012.06.011","volume":"17","author":"GL Warren","year":"2012","unstructured":"Warren GL, Do TD, Kelley BP, Nicholls A, Warren SD (2012) Essential considerations for using protein\u2013ligand structures in drug discovery. Drug Discov Today 17:1270\u20131281","journal-title":"Drug Discov Today"},{"key":"9880_CR69","doi-asserted-by":"crossref","unstructured":"Deller M, Rupp B (2015) Models of protein\u2013ligand crystal structures: trust, but verify. J Comput Aided Mol Des 29:1\u201320","DOI":"10.1007\/s10822-015-9833-8"},{"key":"9880_CR70","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1021\/ci7004093","volume":"48","author":"R Guha","year":"2008","unstructured":"Guha R, Van Drie JH (2008) Structure\u2013activity landscape index: identifying and quantifying activity cliffs. J Chem Inf Model 48:646\u2013658","journal-title":"J Chem Inf Model"},{"key":"9880_CR71","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1021\/ci100258p","volume":"50","author":"G Papadatos","year":"2010","unstructured":"Papadatos G, Alkarouri M, Gillet VJ, Willett P, Kadirkamanathan V, Luscombe CN, Bravi G, Richmond NJ, Pickett SD, Hussain J, Pritchard JM, Cooper AWJ, MacDonald SJF (2010) Lead optimization using matched molecular pairs: inclusion of contextual information for enhanced prediction of hERG inhibition, solubility, and lipophilicity. J Chem Inf Model 50:1872\u20131886","journal-title":"J Chem Inf Model"},{"key":"9880_CR72","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S1359-6446(97)01079-9","volume":"2","author":"H Kubinyi","year":"1997","unstructured":"Kubinyi H (1997) QSAR and 3D QSAR in drug design. Part 1: Methodology. Drug Discov Today 2:457\u2013467","journal-title":"Drug Discov Today"}],"container-title":["Journal of Computer-Aided Molecular Design"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-015-9880-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10822-015-9880-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-015-9880-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,26]],"date-time":"2022-05-26T06:03:07Z","timestamp":1653544987000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10822-015-9880-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,16]]},"references-count":72,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["9880"],"URL":"https:\/\/doi.org\/10.1007\/s10822-015-9880-1","relation":{},"ISSN":["0920-654X","1573-4951"],"issn-type":[{"value":"0920-654X","type":"print"},{"value":"1573-4951","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,16]]}}}